Almotriptan

Exposed non-exposed studies (cohort)

Study Country
Study period
Population source Exposure definition Non-exposure definition Sample size Rmk
Källén (control exposed to ergots), 2011 Sweden
1995 - 2008
All deliveries in Sweden (1 211 670 women) recorded in the Medical Birth Register with data from antenatal care. Infants born to women who had used Almotriptan during pregnancy. (This is a subgroup of exposure among the whole exposed group considered in the study). exposed to other treatment, sick
Infants born to women who had used Ergots drugs for migraine during pregnancy. (This is a subgroup of exposure among the whole exposed group considered in the study).
6 / 527 Exposed groups of the whole study: drugs for migraine (ergots or triptans).
Källén (control unexposed, disease free), 2011 Sweden
1995 - 2008
All deliveries in Sweden (1 211 670 women) recorded in the Medical Birth Register with data from antenatal care. Infants born to women who had used drugs for migraine (triptans or ergots) during pregnancy. Exposure to Almotriptan provided and considered as a separate subgroup. unexposed, disease free
Infants born to women who did not use drugs for migraine.
6 / 1229901 Exposed groups of the whole study: drugs for migraine (ergots or triptans). 1229901= Total number of infants (n=1233228) - Number of infants whose mother used drugs for migraine in 1st trimester (n=3327)

Case-control studies (cohort)

Study Country
Study period
Case Control Sample size Rmk

See the method used to produce these results